News brief: Company says it has new diagnostic test
News brief
Company says it has new diagnostic test
A manufacturer of medical diagnostic test kits says it has completed the development of a new diagnostic test kit to identify individuals who have an antibody that appears to neutralize the HIV virus and prevents HIV infection from progressing into full-blown AIDS.
The company, Hemagen Diagnostics of Columbia, MD, says the test will detect the antibody to an epitope, called R7V, the marker believed to distinguish progressors from non-progressors.
The test is being developed in conjunction with URRMA Biopharma, a Canadian-based biotech company. URRMA has obtained an exclusive global license for the use of a specific antibody (anti-R7V) in a diagnostic test and for the eventual use of the antibody as a therapeutic and preventative treatment for AIDS. Hemagen has an agreement with URRMA to produce this diagnostic kit exclusively for URRMA.
Subscribe Now for Access
You have reached your article limit for the month. We hope you found our articles both enjoyable and insightful. For information on new subscriptions, product trials, alternative billing arrangements or group and site discounts please call 800-688-2421. We look forward to having you as a long-term member of the Relias Media community.